Abstract
Although chronic obstructive pulmonary disease (COPD) is an increasingly important cause of morbidity and mortality in the US, it has been neglected by both the provider and disease management communities partly because of the difficulty in demonstrating financial returns on investment and an absence of evidence-based guidelines and economic evaluations of alternative therapeutic approaches. It is, however, a clinical entity that is amenable to structured disease management with achievable and measurable clinical, financial and health-related quality-of-life outcomes. Program design considerations, population identification and behavior modification approaches are discussed. With limited objective clinical improvement potential in COPD, risk stratification and outcome measurement based on symptom improvement are proposed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Singh GK, Matthews TJ, Clarke SC, et al. Annual summary of births, marriages, divorces and deaths: United States, 1994. Hyattsville, MD: National Center for Health Statistics: monthly vital statistics report, 1994; 43: No. 3
Kesten S, Chapman KR. Physician perceptions and management of COPD. Chest 1993; 104(1): 254–8
Celli BR, Snider GL, Heffner J, et al. Standards for the diagnosis and care of patients and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995; 152 (Suppl.): S77–120
Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000; 117(1): 1146–61
American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Med Crit Care Med 1999; 159(1): 321–40
Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. Chest 1997; 112(5): 1363–96
Ramsey SD. Suboptimal medical therapy in COPD: exploring the causes and consequences. Chest 2000; 117(2 Suppl.): 33S–7S
National Heart, Lung, and Blood Institute (NHLBI), National Asthma Education and Prevention Program. Expert Panet Report 2: guidelines for the diagnosis and management of asthma. Bethesda, Maryland: National Institutes of Health, 1997: Pub. No. 97-4052
National Ambulatory Medical Care Survey. Hyattsville, MD: National Center for Health Statistics, 1996
Strategies in preserving lung health and preventing COPD and associated diseases. The National Lung Health Education Program (NLHEP). Chest 1998; 113 (2 Suppl.): 123S–63S
Global Initiatives for Chronic Obstructive Lung Disease™ (GOLD). Initial recommendations for the management of COPD. Available from: URL: http://www.goldcopd.com/exec_summary/summary_2001/index.html
Bartolome R. Celli. The importance of spirometry in COPD and asthma. Chest 2000; 117(2 Suppl.): 15S–19S
Mahler DA. How should health-related quality of life be assessed in patients with COPD? Chest 2000; 117(2 Suppl.): 54S–57S
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Calhoun, J., Coetzer, H. Respiratory Disease Management. Dis-Manage-Health-Outcomes 9 (Suppl 1), 21–27 (2001). https://doi.org/10.2165/00115677-200109001-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00115677-200109001-00004